Study of ALTO-101 in Patients With Schizophrenia

NCT06502964 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Cognitive Impairment

Interventions

DRUG: ALTO-101
DEVICE: ALTO-101 Transdermal Delivery System
DRUG: Placebo
DEVICE: Placebo Transdermal Delivery System

Sponsor

Alto Neuroscience